ARxIUM delivers best-in-class technology and unparalleled expertise focused on helping pharmacies of all sizes and types improve safety, productivity and efficiency. We provide comprehensive and scalable pharmacy solutions for every segment of the pharmacy market – health systems, long-term care, central fill, mail order, and retail – designed with category-leading automation hardware and workflow software, and supported by unmatched industry knowledge.

MiPC Advisors is a strategy consulting and advisory service for clients seeking to accelerate organic growth and expand product lines or move into new markets through acquisitions. MiPC Advisors delivers strategic insights into the evolving healthcare landscape from the hospital setting to post-acute to the home and recommends commercial strategies to achieve profitable growth, including strategic positioning, product innovation and development, and organizational restructuring and alignment. With industry and technology expertise, MiPC Advisors guides clients through their digital business transformation, leveraging enterprise business intelligence and data science to optimize operations, the customer experience, and care delivery models. Clients include market participants and institutional investors.

Medical Solutions is an industry leading workforce solutions company, delivering travel nursing and allied health staffing services in acute and post-acute care settings. Recruited by TPG private equity to provide strategic direction to the commercial and technology teams, drive operational excellence, and position the company for an exit. Served as a primary lead for the strategic process, drafted the CIP, and presented to potential buyers. Oversaw commercial strategy, sales and operations, marketing, innovation and product development, information technology, data science, and development of artificial intelligence solutions. Developed the digital transformation vision for Total Workforce Solutions, product roadmap, and commercial strategies to achieve a frictionless customer experience through a combination of enterprise data intelligence, apps, user portals, and machine-learning algorithms to optimize job matching and service delivery.Achievements:- Achieved a successful exit with a $2.3 billion sale of the company- Restructured and realigned commercial operations, marketing, product development, and technology organizations, while delivering 101% growth in revenues- Defined vision and strategy to drive company-wide digital transformation: 5-year strategy and product roadmaps with scaled technology capabilities and differentiated solutions

Executive Vice President, Marketing, Strategy and Business Development and member of CEO staff at Omnicell, the market and technology leader for medication, supply management, and adherence solutions for healthcare systems and retail pharmacies. Led global marketing, strategy and business development, while serving as general manager for a cloud-based predictive analytics business using AI-machine learning. Global responsibility for positioning, messaging, pricing, and go-to-market strategies. Developed and led the execution of company’s growth strategies by identifying adjacency moves, acquisitions, and partnership opportunities. Defined and spearheaded the digital business transformation of Omnicell with a comprehensive go-to-market strategy, portfolio planning and prioritization, and market segmentation. Oversaw portfolio management to focus resources and investments to develop the digital medication management platform and next generation technologies. Responsible for positioning, branding, and messaging of Omnicell as “The Autonomous Pharmacy Company.”Achievements:- 30X increase in total enterprise value from $200 million in 2009 to over $6 billion in 2021- Revenue growth from $200 million in 2009 to $1.1 billion in 2021- Led 12 acquisitions, including McKesson Automation-Aesynt ($275 million), PSG 340B ($225 million), and MTS Medication Technologies ($155 million), which produced 60% of the company’s overall revenue growth over the 12-year period

Global Vice President, Business Development and member of senior leadership team. Defined growth strategies, assessed new technologies, negotiated deal structure and terms, led due diligence, and planned post-merger integration. - Formulated growth strategies and led technology planning, landscape and assessment of opportunities for a $1.5 billion business unit with 6 classes of trade: patient monitoring, ventilation, sleep diagnostic and therapy, airway management, temperature, and oxygen therapy- Led cross-functional teams to develop acquisition strategies, implemented business development infrastructure, and drove M&A and strategic partnership activities, with a total NPV exceeding $1 billion.

Executive Vice President, Chief Operating Officer and member of the executive committee. Leader of a start-up to publicly-traded, direct-to-consumer technology company (NASDAQ: BSML) later acquired by a strategic. Oversaw multi-channel distribution and operations, including sales, strategic marketing, engineering, quality and regulatory affairs, manufacturing, human resources, and legal.- Developed a new market and established a network of over 5,000 dental practices using the BriteSmile technology- Created and executed go-to-market strategies for 6 product launches, and scaled the business from startup to $46 million in revenues- Led the sale and transition of the company's dental practice division to a strategic buyer

Corporate Associate. Advised clients on SEC reporting and compliance. Drafted and negotiated definitive agreements for technology outsourcing, M&A, and partnerships.